View Single Post
Old 12-18-2007, 11:16 AM   #2
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,783
SABCS abstract number...link please!

SABCS 2007: ABSTRACT #23: Fulvestrant 500 mg vs 250 mg: first results from NEWEST, a randomized, phase II neoadjuvant trial in postmenopausal women with locally advanced, estrogen receptor-positive breast cancer
[
Lani is offline   Reply With Quote